New Market Research Report: Pronota NV - Product Pipeline Analysis, 2014 Update
Pronota NV (PNV) is a diagnostic service provider. It develops and commercializes diagnostics for early detection of life-threatening conditions and unmet medical conditions. The company provides diagnostics for heart failure, pre-eclampsia and sepsis. The company has four programs in its pipeline which includes protein diagnostic blood tests and protein biomarkers. Its products are used in the areas of heart failure, cardio-renal, pre-eclampsia and sepsis. PNV's lead heart failure marker CD146 has multiple clinical utilities. The technology platforms of the company...
View full press release